Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist

Jocelyn A. Kramer; D. Curran; M. Piccart; J.C.J.M. Haes de; P.F. Bruning; J.G.M. Klijn; M. Bontenbal; C. Pottelsberghe van; Mogens Grønvold; R. Paridaens

Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist

Jocelyn A. Kramer, D. Curran, M. Piccart, J.C.J.M. Haes de, P.F. Bruning, J.G.M. Klijn, M. Bontenbal, C. Pottelsberghe van, Mogens Grønvold, R. Paridaens

Afdeling for Sundhedstjenesteforskning

38 Citationer (Scopus)

Abstract

Cancer, Health-related quality of life

Originalsprog	Engelsk
Tidsskrift	European Journal of Cancer
Udgave nummer	36
Sider (fra-til)	1488-1497
ISSN	0959-8049
Status	Udgivet - 2000

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Citationsformater

Kramer, J. A., Curran, D., Piccart, M., Haes de, J. C. J. M., Bruning, P. F., Klijn, J. G. M., Bontenbal, M., Pottelsberghe van, C., Grønvold, M., & Paridaens, R. (2000). Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist. European Journal of Cancer, (36), 1488-1497.

Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist. / Kramer, Jocelyn A.; Curran, D.; Piccart, M. et al.

I: European Journal of Cancer, Nr. 36, 2000, s. 1488-1497.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Kramer, JA, Curran, D, Piccart, M, Haes de, JCJM, Bruning, PF, Klijn, JGM, Bontenbal, M, Pottelsberghe van, C, Grønvold, M & Paridaens, R 2000, 'Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist', European Journal of Cancer, nr. 36, s. 1488-1497.

@article{346cfa4074c811dbbee902004c4f4f50,

title = "Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist",

abstract = "Cancer, Health-related quality of life",

author = "Kramer, {Jocelyn A.} and D. Curran and M. Piccart and {Haes de}, J.C.J.M. and P.F. Bruning and J.G.M. Klijn and M. Bontenbal and {Pottelsberghe van}, C. and Mogens Gr{\o}nvold and R. Paridaens",

year = "2000",

language = "English",

pages = "1488--1497",

journal = "European Journal of Cancer, Supplement",

issn = "0959-8049",

publisher = "Pergamon",

number = "36",

}

TY - JOUR

T1 - Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist

AU - Kramer, Jocelyn A.

AU - Curran, D.

AU - Piccart, M.

AU - Haes de, J.C.J.M.

AU - Bruning, P.F.

AU - Klijn, J.G.M.

AU - Bontenbal, M.

AU - Pottelsberghe van, C.

AU - Grønvold, Mogens

AU - Paridaens, R.

PY - 2000

Y1 - 2000

N2 - Cancer, Health-related quality of life

AB - Cancer, Health-related quality of life

M3 - Journal article

SN - 0959-8049

SP - 1488

EP - 1497

JO - European Journal of Cancer, Supplement

JF - European Journal of Cancer, Supplement

IS - 36

ER -